×
Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study PDF
$ 40.00
Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study PDF quantity
$ 40.00
×
Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
A Preliminary Double-Blind, Placebo-Controlled Trial of Divalproex Sodium in Borderline Personality Disorder PDF
$ 40.00
A Preliminary Double-Blind, Placebo-Controlled Trial of Divalproex Sodium in Borderline Personality Disorder PDF quantity
$ 40.00
×
Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest Schools PDF
$ 40.00
Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest Schools PDF quantity
$ 40.00
×
A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia PDF
$ 40.00
A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia PDF quantity
$ 40.00
×
Sex Differences in the Prevalence and Clinical Features of Comorbid Depressive Symptoms in Never-Treated Chinese Patients With First-Episode Schizophrenia PDF
$ 40.00
Sex Differences in the Prevalence and Clinical Features of Comorbid Depressive Symptoms in Never-Treated Chinese Patients With First-Episode Schizophrenia PDF quantity
$ 40.00
×
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder PDF
$ 40.00
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart